Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature ; volume:2 ; number:03 ; year:2012 ; pages:71-73
Avicenna journal of medicine ; 2, Heft 03 (2012), 71-73
- Contributor
-
Firwana, Belal
Atassi, Bassel
Hasan, Rim
Hasan, Nour
Sukari, Ammar
- DOI
-
10.4103/2231-0770.102282
- URN
-
urn:nbn:de:101:1-2021090814560621436370
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Firwana, Belal
- Atassi, Bassel
- Hasan, Rim
- Hasan, Nour
- Sukari, Ammar
Other Objects (12)
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Pictorial essay: Salivary gland imaging
Salivary gland diseases in children
Bioengineering in salivary gland regeneration
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Pictorial essay: Salivary gland imaging
Salivary gland diseases in children
Bioengineering in salivary gland regeneration
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
Systemic therapy for recurrent or metastatic salivary gland malignancies
Salivary gland neoplasms
Salivary Gland Cytopathology
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Salivary gland tumors : 52 tables
Pictorial essay: Salivary gland imaging
Salivary gland diseases in children